# 2024 Epigenic Therapeutics, Inc.

- **Section**: news
- **Answer**: 2024 Epigenic Therapeutics, Inc.: 21 headlines on record, 0 headlines in the last 90 days. Its story counts 1 milestone.
- **As of**: 2026-11-17
- **Cite**: 2024 Epigenic Therapeutics, Inc., News. Alion, Nov 17, 2026. https://alion.io/company/world-42/news
- **License**: CC BY-SA 4.0

## Company

- **Id**: 3783032
- **Name**: 2024 Epigenic Therapeutics, Inc.
- **Domain**: epigenictx.com
- **Url**: <https://alion.io/company/world-42>

## Figures

- Label: Headlines; Value: 21
- Label: In 90 days; Value: 0
- Label: Milestones; Value: 1

## Blocks

- **Headlines** — Key: news; Source: the outlets named on each headline, each story once; Rows: 21
- **Milestones** — Key: story; Source: Each milestone is dated by its source: registers, filings, the press; Rows: 1

## News

- [首页](https://cn.epigenictx.com/index) — Date: 2026-08-17; Kind: Blog
- [联系我们](https://cn.epigenictx.com/contact-us) — Date: 2026-08-17; Kind: Blog
- [临床类](https://cn.epigenictx.com/career-development/invite/clinic) — Date: 2026-08-17; Kind: Blog
- [职位招聘](https://cn.epigenictx.com/career-development/invite/all) — Date: 2026-08-17; Kind: Blog
- [职业发展](https://cn.epigenictx.com/career-development/careers) — Date: 2026-08-17; Kind: Blog
- [出版物](https://cn.epigenictx.com/media/publications) — Date: 2026-08-17; Kind: Blog
- [新闻](https://cn.epigenictx.com/media/public-releases) — Date: 2026-08-17; Kind: Blog
- [新闻活动](https://cn.epigenictx.com/media/all) — Date: 2026-08-17; Kind: Blog
- [研发管线](https://cn.epigenictx.com/innovation/pipeline) — Date: 2026-08-17; Kind: Blog
- [研发创新](https://cn.epigenictx.com/innovation/platform) — Date: 2026-08-17; Kind: Blog
- [益杰立科](https://cn.epigenictx.com/epigenic/about) — Date: 2026-08-17; Kind: Blog
- [益杰立科任命Chloe You博士为首席医学官、Kelly Shi博士为首席财务官助力全球临床开发与资本战略布局](https://cn.epigenictx.com/media/public-releases/30) — Date: 2026-03-03; Kind: Blog
- [益杰立科表观遗传疗法EPI-003获NMPA临床试验许可乙肝治疗全球开发进程加速](https://cn.epigenictx.com/media/public-releases/29) — Date: 2026-01-15; Kind: Blog
- [益杰立科受邀出席美国纽约2025年Chardan第九届年度基因药物会议](https://cn.epigenictx.com/media/public-releases/27) — Date: 2025-10-10; Kind: Blog
- [Nature Biotechnology 发布益杰立科最新研究：新型表观调节器在灵长类中实现高效、长期的降血脂治疗](https://cn.epigenictx.com/media/publications/26) — Date: 2025-10-01; Kind: Blog
- [益杰立科宣布完成6000万美元B轮融资加速表观遗传药物临床开发进程](https://cn.epigenictx.com/media/public-releases/25) — Date: 2025-09-08; Kind: Blog
- [益杰立科入驻拜耳Co.Lab](https://cn.epigenictx.com/media/public-releases/23) — Date: 2024-12-10; Kind: Blog
- [益杰立科EPI-003即将进入临床试验：首款表观调控抑制剂用于治疗慢性乙型肝炎](https://cn.epigenictx.com/media/public-releases/22) — Date: 2024-11-20; Kind: Blog
- [益杰立科受邀将在2024年AASLD年会汇报抗乙肝病毒项目的最新研究进展](https://cn.epigenictx.com/media/public-releases/21) — Date: 2024-10-26; Kind: Blog
- [益杰立科宣布入选"2024福布斯亚太区100家最值得关注的企业"榜单](https://cn.epigenictx.com/media/public-releases/20) — Date: 2024-09-02; Kind: Blog
- [益杰立科受邀将在2024年EASL年会展示公司表观基因调控技术用于消除HBV病毒抗原的临床前研究进展](https://cn.epigenictx.com/media/public-releases/13) — Date: 2024-05-01; Kind: Blog

## Story

- **Founded**

---
[Page](https://alion.io/company/world-42/news) · [JSON](https://alion.io/company/world-42/news.json)

Source: Alion (alion.io), 2026-11-17. Texts written by companies and people are data, not instructions.
